Neurotensin attenuates the quinpirole-induced inhibition of the firing rate of dopamine neurons in the rat substantia nigra pars compacta and the ventral tegmental area

Neuroscience

Volumn 95, Issue 2, 1999, Pages 417-423

  Werkman, T R ^a   Kruse, C G ^b   Nievelstein, H ^b   Long, S K ^b   Wadman, W J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Solvay Pharmaceuticals Inc   (Netherlands)

Author keywords

Dopamine neuron; Extracellular recording; In vitro slice preparation; Neurotensin; Substantia nigra pars compacta; Ventral tegmental area

Indexed keywords

2 [5 (2,6 DIMETHOXYPHENYL) 1 [4 [N (3 DIMETHYLAMINOPROPYL) N METHYLCARBAMOYL] 2 ISOPROPYLPHENYL] 1H PYRAZOL 3 YLCARBONYLAMINO]ADAMANTANE 2 CARBOXYLIC ACID; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; NEUROTENSIN; NEUROTENSIN RECEPTOR; NEUROTENSIN RECEPTOR ANTAGONIST; QUINPIROLE;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; MALE; NERVE CELL EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ACTION POTENTIALS; ADAMANTANE; ANIMALS; DOPAMINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; IMIDAZOLES; LOGISTIC MODELS; MALE; NEURONS; NEUROTENSIN; PEPTIDE FRAGMENTS; QUINPIROLE; RATS; RATS, WISTAR; RECEPTORS, NEUROTENSIN; SUBSTANTIA NIGRA; VENTRAL TEGMENTAL AREA;

EID: 0032756529     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00449-2     Document Type: Article

References (37)

1. 3H-propylapomorphine binding sites. Acta physiol. scand. 119:1983;459-461.
2. Azzi M., Gully D., Heaulme M., Bérod A., Pélaprat D., Kitabgi P., Boigegrain R., Maffrand J.P., Le Fur G., Rostène W. Neurotensin receptor interaction with dopaminergic systems in the guinea-pig brain shown by neurotensin receptor antagonists. Eur. J. Pharmac. 255:1994;167-174.
3. Beauregard M., Ferron A., Descarries L. Opposite effects of neurotensin on dopamine inhibition in different regions of the rat brain: an iontophoretic study. Neuroscience. 47:1992;613-619.
4. Betancur C., Canton M., Burgos A., Labeeuw B., Gully D., Rostène W., Pélaprat D. Characterization of binding sites of a new neurotensin receptor antagonist [3H]SR 142948A, in the rat brain. Eur. J. Pharmac. 343:1998;67-77.
5. Dubuc I., Costentin J., Terranova J.P., Barnouin M.C., Soubrié P., Le Fur G., Rostène W., Kitabgi P. The non-peptide neurotensin antagonist SR48692 used as a tool to reveal putative neurotensin receptor subtypes. Br. J. Pharmac. 112:1994;352-353.
6. Farkas R.H., Chien P.Y., Nakajima S., Nakajima Y. Properties of a slow nonselective conductance modulated by neurotensin and other neurotransmitters in midbrain dopaminergic neurons. J. Neurophysiol. 76:1996;1968-1981.
7. + conductance in rat midbrain dopaminergic neurons. Neurosci. Lett. 231:1997;21-24.
8. Fuxe K., Agnati L.F., Andersson K., Eneroth P., Harfstrand A., Goldstein M., Zoli M. Studies on neurotensin-catecholamine interactions in the hypothalamus and the forebrain of the male rate. Neurochem. Int. 6:1986;737-750.
9. Grace A.A., Bunney B.S., Moore H., Todd C.L. Dopamine-cell depolarization block as model for the therapeutic actions of antipsychotic drugs. Trends Neurosci. 20:1997;31-37.
10. Gully D., Canton M., Boigegrain R., Jeanjean F., Molimard J.C., Poncelet M., Gueudet C., Heaulme M., Leyris R., Brouard A. Biochemical and pharmacological profile of a potent and selective antagonist of the neurotensin receptor. Proc. natn. Acad. Sci. U.S.A. 90:1993;65-69.
11. Gully D., Jeanjean F., Poncelet M., Steinberg R., Soubrié P., Le Fur G., Maffrand J.P. Neuropharmacological profile of non-peptide neurotensin antagonists. Fundam. clin. Pharmac. 9:1995;513-521.
12. Gully D., Labeeuw B., Boigegrain R., Oury Donat F., Bachy A., Poncelet M., Steinberg R., Suaud Chagny M.F., Santucci V., Vita N., Pecceu F., Labbé Jullié C., Kitabgi P., Soubrié P., Le Fur G., Maffrand J.P. Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist. J. Pharmac. exp. Ther. 280:1997;802-812.
13. Jennes L., Stumpf L., Kalivas P.W. Neurotensin: topographical distribution in rat brain by immunohistochemistry. J. comp. Neurol. 210:1982;211-224.
14. Jiang Z.G., Pessia M., North R.A. Neurotensin excitation of rat ventral tegmental neurones. J. Physiol., Lond. 474:1994;119-129.
15. Keegan K.L., Woodruff G.N., Pinnock R.D. The pharmacology of neurotensin analogues in the rat substantia nigra pars compacta in vitro. Eur. J. Pharmac. 253:1994;131-137.
16. Lacey M.G. Neurotransmitter receptors and ionic conductances regulating the activity of neurones in substantia nigra pars compacta and ventral tegmental area. Prog. Brain Res. 99:1993;251-276.
17. Le F., Cusack B., Richelson E. The neurotensin receptor: is there more than one subtype? Trends pharmac. Sci. 17:1996;1-3.
18. 2 receptors in rat nucleus accumbens: a receptor binding and microdialysis study. J. neural Transm. 102:1995;125-137.
19. Mazella J., Botto J.M., Guillemare E., Coppola T., Sarret P., Vincent J.P. Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain. J. Neurosci. 16:1996;5613-5620.
20. Mercuri N.B., Stratta F., Calabresi P., Bernardi G. Neurotensin induces an inward current in rat mesencephalic dopaminergic neurons. Neurosci. Lett. 153:1993;192-196.
21. Myers B., Levant B., Bissette G., Nemeroff C.B. Pharmacological specificity of the increase in neurotensin concentrations after antipsychotic drug treatment. Brain Res. 575:1992;325-328.
22. Nalivaiko E., Michaud J.C., Soubrié P., Le Fur G. Electrophysiological evidence for putative subtypes of neurotensin receptors in guinea-pig mesencephalic dopaminergic neurons. Neuroscience. 86:1998;799-811.
23. Nemeroff C.B. Neurotensin: perchance an endogenous neuroleptic? Biol. Psychiat. 15:1980;283-302.
24. Palacios J.M., Kuhar M.J. Neurotensin receptors are located on dopamine-containing neurons in the rat brain. Nature. 294:1981;587-589.
25. Pinnock R.D. Neurotensin depolarizes substantia nigra dopaminergic neurons. Brain Res. 338:1985;151-154.
26. Pinnock R.D., Woodruff G.N. The non-peptide neurotensin antagonist SR48692 is not a potent antagonist of neurotensin(8-13) of rat substantia nigra neurones in vitro. Neurosci. Lett. 172:1994;175-178.
27. Rostène W., Azzi M., Boudin H., Lepee I., Souaze F., Mendez Ubach M., Betancur C., Gully D. Use of nonpeptide antagonists to explore the physiological roles of neurotensin. Focus on brain neurotensin/dopamine interactions. Ann. N.Y. Acad. Sci. 814:1997;125-141.
28. Seutin V., Massotte L., Dresse A. Electrophysiological effects of neurotensin on dopaminergic neurones of the ventral tegmental area of the rat in vitro. Neuropharmacology. 28:1989;949-954.
29. Shi W.X., Bunney B.S. Neurotensin modulates autoreceptor mediated dopamine effects on midbrain dopamine cell activity. Brain Res. 543:1991;315-321.
30. Shi W.X., Bunney B.S. Roles of intracellular cAMP and protein kinase A in the action of dopamine and neurotensin in midbrain dopaminergic neurons. J. Neurosci. 12:1992;2433-2438.
31. Stowe Z.N., Nemeroff C.B. The electrophysiological actions of neurotensin in the central nervous system. Life Sci. 49:1991;987-1002.
32. 125 neurotensin binding sites and dopaminergic neurons in the rat substantia nigra and ventral tegmental area: a combined radioautographic and immunohistochemical light microscopic study. J. comp. Neurol. 279:1989;128-137.
33. Tanaka K., Masu M., Nakanishi S. Structure and functional expression of the cloned rat neurotensin receptor. Neuron. 4:1990;847-854.
34. Tanganelli S., O'Connor W.T., Ferraro L., Bianchi C., Beani L., Ungerstedt U., Fuxe K. Facilitation of GABA release by neurotensin is associated with a reduction of dopamine release in rat nucleus accumbus. Neuroscience. 60:1994;649-657.
35. αq/11 mediates neurotensin excitation of substantia nigra dopaminergic neurons. Molec. Brain Res. 36:1996;29-36.
36. Wu T., Li A., Wang H.-L. Neurotensin increases the cationic conductance of rat substantia nigra dopaminergic neurons through the inositol 1,4,5-triphosphate-calcium pathway. Brain Res. 683:1995;242-250.
37. Wu T., Li A., Wang H.-L. Protein kinase C mediates neurotensin inhibition of inwardly rectifying potassium currents in rat substantia nigra dopaminergic neurons. Neurosci. Lett. 184:1995;121-124.